Lehrstuhl für Genetik

Low-Dose Radiotherapy Leads to a Systemic Anti-Inflammatory Shift in the Pre-Clinical K/BxN Serum Transfer Model and Reduces Osteoarthritic Pain in Patients (2022) Weissmann T, Rückert M, Zhou J, Seeling M, Lettmaier S, Donaubauer AJ, Nimmerjahn F, et al. Journal article Impaired B Cell Expression of the Inhibitory Fcγ Receptor IIB in Myasthenia Gravis (2022) Keller CW, Chuquisana O, Derdelinckx J, Gross CC, Berger K, Robinson J, Nimmerjahn F, et al. Journal article Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus (2022) Mackensen A, Müller F, Mougiakakos D, Böltz S, Wilhelm A, Aigner M, Völkl S, et al. Journal article Direct Impact of Human Platelets on the Development of Transplant Arteriosclerosis. (2022) Görner S, Heim C, Weigmann B, Von Silva-Tarouca B, Kuckhahn A, Ramsperger-Gleixner M, Zimmermann R, et al. Journal article The C5a/C5aR1 axis drives autoimmune inflammation in pemphigoid disease through the control of early Tfh cell activation, IgG autoantibody formation and IgG Fc-glycan composition (2022) Kenno S, Gieseler-Tillmann J, Kordowski A, Borus S, Bieber K, Ludwig R, Lux A, et al. Conference contribution Small but powerful: will nanoparticles be the future state‐of‐the‐art therapy for IBD? (2022) Lechner K, Zeeshan M, Noack M, Ali H, Neurath M, Weigmann B Journal article, Review article Tilting the Balance: Therapeutic Prospects of CD83 as a Checkpoint Molecule Controlling Resolution of Inflammation (2022) Peckert-Maier K, Royzman D, Langguth P, Marosán A, Strack A, Sadeghi Shermeh A, Steinkasserer A, et al. Journal article, Review article Next-generation antibody-based therapies in neurology (2021) Ruck T, Nimmerjahn F, Wiendl H, Luenemann JD Journal article, Review article Low-Salt Diet Attenuates B-Cell- and Myeloid-Cell-Driven Experimental Arthritides by Affecting Innate as Well as Adaptive Immune Mechanisms (2021) Sehnert B, Pohle S, Heuberger C, Rzepka R, Seidl M, Nimmerjahn F, Chevalier N, et al. Journal article SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself (2021) Ferreira-Gomes M, Kruglov A, Durek P, Heinrich F, Tizian C, Heinz GA, Pascual-Reguant A, et al. Journal article